{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:42:11Z","timestamp":1785577331138,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES02710"],"award-info":[{"award-number":["ES02710"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P42 ES04699"],"award-info":[{"award-number":["P42 ES04699"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["vaajournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Anaesthesia and Analgesia"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1111\/vaa.12030","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T03:51:48Z","timestamp":1362628308000},"page":"440-448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis"],"prefix":"10.1016","volume":"40","author":[{"given":"Alonso GP","family":"Guedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Morisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Sole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao HN","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Ulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/vaa.12030_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2746\/042516407X155406","article-title":"Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response","volume":"39","author":"Belknap","year":"2007","journal-title":"Equine Vet J"},{"key":"10.1111\/vaa.12030_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.phrs.2005.04.004","article-title":"COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis","volume":"52","author":"Beretta","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1111\/vaa.12030_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.rvsc.2007.10.011","article-title":"Development of a composite orthopaedic pain scale in horses","volume":"85","author":"Bussieres","year":"2008","journal-title":"Res Vet Sci"},{"key":"10.1111\/vaa.12030_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FJC.0b013e3181506445","article-title":"The soluble epoxide hydrolase as a pharmaceutical target for hypertension","volume":"50","author":"Chiamvimonvat","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/vaa.12030_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2460\/javma.231.5.755","article-title":"Gabapentin for the treatment of neuropathic pain in a pregnant horse","volume":"231","author":"Davis","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"10.1111\/vaa.12030_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00204-009-0416-0","article-title":"Mammalian epoxide hydrolases in xenobiotic metabolism and signalling","volume":"83","author":"Decker","year":"2009","journal-title":"Arch Toxicol"},{"key":"10.1111\/vaa.12030_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cveq.2010.04.002","article-title":"Neuropathic pain management in chronic laminitis","volume":"26","author":"Driessen","year":"2010","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1111\/vaa.12030_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1213\/00000539-200007000-00035","article-title":"Gabapentin enhances the analgesic effect of morphine in healthy volunteers","volume":"91","author":"Eckhardt","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1111\/vaa.12030_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0749-0739(17)30148-7","article-title":"The pathophysiology of developmental and acute laminitis","volume":"15","author":"Hood","year":"1999","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1111\/vaa.12030_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1939-1676.1993.tb01012.x","article-title":"The role of vascular mechanisms in the development of acute equine laminitis","volume":"7","author":"Hood","year":"1993","journal-title":"J Vet Intern Med"},{"key":"10.1111\/vaa.12030_bib11","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1021\/jm070270t","article-title":"Orally bioavailable potent soluble epoxide hydrolase inhibitors","volume":"50","author":"Hwang","year":"2007","journal-title":"J Med Chem"},{"key":"10.1111\/vaa.12030_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/vaa.12030_bib13","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.lfs.2006.07.031","article-title":"Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain","volume":"79","author":"Inceoglu","year":"2006","journal-title":"Life Sci"},{"key":"10.1111\/vaa.12030_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.prostaglandins.2006.05.004","article-title":"Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)","volume":"82","author":"Inceoglu","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1111\/vaa.12030_bib15","doi-asserted-by":"crossref","first-page":"18901","DOI":"10.1073\/pnas.0809765105","article-title":"Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways","volume":"105","author":"Inceoglu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/vaa.12030_bib16","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1073\/pnas.1101073108","article-title":"Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP","volume":"108","author":"Inceoglu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/vaa.12030_bib17","doi-asserted-by":"crossref","first-page":"11390","DOI":"10.1073\/pnas.1208708109","article-title":"Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes","volume":"109","author":"Inceoglu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/vaa.12030_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pain.2007.08.035","article-title":"Neuropathic changes in equine laminitis pain","volume":"132","author":"Jones","year":"2007","journal-title":"Pain"},{"key":"10.1111\/vaa.12030_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2460\/ajvr.2000.61.152","article-title":"Hepatic and pulmonary enzyme activities in horses","volume":"61","author":"Lakritz","year":"2000","journal-title":"Am J Vet Res"},{"key":"10.1111\/vaa.12030_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neulet.2006.11.022","article-title":"Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain","volume":"412","author":"Liu","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1111\/vaa.12030_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/anatox\/35.2.75","article-title":"Analysis of gabapentin in equine plasma with measurement uncertainty estimation by liquid chromatography-tandem mass spectrometry","volume":"35","author":"Liu","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1111\/vaa.12030_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","article-title":"Immune and inflammatory mechanisms in neuropathic pain","volume":"51","author":"Moalem","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1111\/vaa.12030_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.pharmtox.45.120403.095920","article-title":"Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles","volume":"45","author":"Morisseau","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1111\/vaa.12030_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ps.1583","article-title":"Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical","volume":"64","author":"Morisseau","year":"2008","journal-title":"Pest Manag Sci"},{"key":"10.1111\/vaa.12030_bib25","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1016\/j.bmcl.2006.07.073","article-title":"Peptidyl-urea based inhibitors of soluble epoxide hydrolases","volume":"16","author":"Morisseau","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1111\/vaa.12030_bib26","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.M006007","article-title":"Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids","volume":"51","author":"Morisseau","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1111\/vaa.12030_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1538\/expanim.60.7","article-title":"Lipid mediators in life science","volume":"60","author":"Murakami","year":"2011","journal-title":"Exp Anim"},{"key":"10.1111\/vaa.12030_bib28","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1111\/vaa.12030_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0749-0739(03)00019-1","article-title":"Chronic laminitis: current treatment strategies","volume":"19","author":"Parks","year":"2003","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1111\/vaa.12030_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1152\/japplphysiol.00794.2005","article-title":"Predisposition for venoconstriction in the equine laminar dermis: implications in equine laminitis","volume":"100","author":"Peroni","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1111\/vaa.12030_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.coph.2009.12.002","article-title":"Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man","volume":"10","author":"Revermann","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/vaa.12030_bib32","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.0503279102","article-title":"Soluble epoxide hydrolase is a therapeutic target for acute inflammation","volume":"102","author":"Schmelzer","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/vaa.12030_bib33","doi-asserted-by":"crossref","first-page":"13646","DOI":"10.1073\/pnas.0605908103","article-title":"Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors","volume":"103","author":"Schmelzer","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/vaa.12030_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0749-0739(17)30157-8","article-title":"Pharmacologic and alternative therapies for the horse with chronic laminitis","volume":"15","author":"Sumano Lopez","year":"1999","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1111\/vaa.12030_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-0739(02)00009-3","article-title":"Diagnosing and treating pain in the horse. Where are we today?","volume":"18","author":"Taylor","year":"2002","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1111\/vaa.12030_bib36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2460\/ajvr.2004.65.456","article-title":"Effects of glycopyrrolate on cardiorespiratory function in horses anesthetized with halothane and xylazine","volume":"65","author":"Teixeira Neto","year":"2004","journal-title":"Am J Vet Res"},{"key":"10.1111\/vaa.12030_bib37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2885.2010.01161.x","article-title":"Pharmacokinetic profile and behavioral effects of gabapentin in the horse","volume":"33","author":"Terry","year":"2010","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1111\/vaa.12030_bib38","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1248\/bpb.34.1174","article-title":"Unsaturated Fatty acids and pain","volume":"34","author":"Tokuyama","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1111\/vaa.12030_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejps.2010.03.018","article-title":"Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs","volume":"40","author":"Tsai","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1111\/vaa.12030_bib40","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1476-5381.2011.01641.x","article-title":"Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys","volume":"165","author":"Ulu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1111\/vaa.12030_bib41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.bjp.0705999","article-title":"Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain","volume":"143","author":"Vale","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1111\/vaa.12030_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tvjl.2010.05.011","article-title":"Comparison of subjective scoring systems used to evaluate equine laminitis","volume":"188","author":"Vinuela-Fernandez","year":"2011","journal-title":"Vet J"},{"key":"10.1111\/vaa.12030_bib43","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1021\/jf102559q","article-title":"Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction","volume":"59","author":"Wagner","year":"2011","journal-title":"J Agric Food Chem"},{"key":"10.1111\/vaa.12030_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prostaglandins.2011.08.001","article-title":"Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception","volume":"96","author":"Wagner","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1111\/vaa.12030_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jat\/33.1.41","article-title":"Screening, quantification, and confirmation of phenylbutazone and oxyphenbutazone in equine plasma by liquid chromatography-tandem mass spectrometry","volume":"33","author":"You","year":"2009","journal-title":"J Anal Toxicol"},{"key":"10.1111\/vaa.12030_bib46","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ Res"}],"container-title":["Veterinary Anaesthesia and Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1467298716302914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1467298716302914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T02:51:13Z","timestamp":1761447073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1467298716302914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1467298716302914"],"URL":"https:\/\/doi.org\/10.1111\/vaa.12030","relation":{},"ISSN":["1467-2987"],"issn-type":[{"value":"1467-2987","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis","name":"articletitle","label":"Article Title"},{"value":"Veterinary Anaesthesia and Analgesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/vaa.12030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}